European Medicines Agency Recommends Approving Takeda’s Dengue Vaccine
In clinical trials, the new inoculation demonstrated greater protection for children and people older than 45 than the existing dengue vaccine.
Source: The Scientist - Category: Science Tags: News & Opinion Source Type: news
More News: Children | Clinical Trials | Dengue Fever | European Medicines Agency (EMA) | Science | Vaccines